Uchikawa, Tomoki
Matoba, Tetsuya
Kawahara, Takuro
Baba, Isashi
Katsuki, Shunsuke
Koga, Jun-ichiro
Hashimoto, Yu
Yamasaki, Ryo
Ichi, Ikuyo
Akita, Hidetaka
Tsutsui, Hiroyuki
Funding for this research was provided by:
JSPS KAKENHI (21H02916)
JST, CREST (17941843)
Article History
Received: 15 February 2022
Accepted: 24 August 2022
First Online: 1 September 2022
Competing interests
: TM has received personal fees (Abbott, Bayer Yakuhin, and MSD) and research funding (Kowa, Amgen and Bayer Yakuhin) outside the submitted work. HT has received lecture fees (Kowa, Teijin Pharma, Nippon Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Pfizer Japan, Ono Pharmaceutical, Daiichi Sankyo, Novartis Pharma, Bayer Yakuhin, Otsuka Pharmaceuticalm, and AstraZeneca), manuscript fees (Nippon Rinsho), research funding (Mitsubishi Tanabe Pharma, Nippon Boehringer Ingelheim, IQVIA Services Japan, MEDINET, Medical Innovation Kyushu, Kowa, Daiichi Sankyo, Johnson & Johnson, and NEC Corporation) and scholarship funds (Abbott Medical Japan, Otsuka Pharmaceutical, Boston Scientific Japan, Ono Pharmaceutical, Bayer Yakuhin, Nippon Boehringer Ingelheim, St. Mary's Hospital, Teijin Pharma, Daiichi Sankyo, and Mitsubishi Tanabe Pharma) outside the submitted work. The other authors report no conflicts.